Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05472740 · ClinicalTrials.gov registry record · NA

Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy

A NA study of Pain, Postoperative and Endometrial Diseases, sponsored by Duke University.

Completed
Registry status
NA
Development phase
149
Enrollment target
1
Study location

NCT05472740: Completed NA study of Pain, Postoperative and Endometrial Diseases, sponsored by Duke University.

NCT05472740 is a NA study of Pain, Postoperative and Endometrial Diseases that has completed, run by Duke University. The registered enrollment target is 149 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05472740, a NA study of Pain, Postoperative and Endometrial Diseases, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether transcutaneous electrical nerve stimulation (or TENS) reduces pain during an endometrial biopsy. A TENS unit is an over-the-counter, FDA approved device that sends low-level electrical impulses through the skin to reduce the amount of discomfort experienced during procedures. A TENS unit is very low-risk and used in a lot of ways, including for chronic pain, after surgery, and during labor. Since there is no standard way of managing discomfort during an endometrial biopsy, the investigators think that TENS might be helpful. Participating in the study may require some additional time in clinic to answer research-related questions. Subjects will be asked to answer demographic questions (which will be combined anonymously) before and after the procedure, as well as rate subject's pain at different time points during the procedure. The biggest benefit in participating is that subject's discomfort might be lower during and after the procedure. Subjects may not benefit from participating in this study. There is a small risk of a skin reaction from wearing the TENS pads.

Primary Outcome

Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain

Interventions

  • DEVICE TENS 7000

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2022-12-13
Est. Completion 2023-12-26
Phase NA
Duke University

1,725 total trials

What the finished NCT05472740 record still lists

NCT05472740 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (45% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which TENS 7000 is the first listed.

NCT05472740 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05472740 about?

NCT05472740 is a clinical study titled "Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy". The purpose of this study is to see whether transcutaneous electrical nerve stimulation (or TENS) reduces pain during an endometrial biopsy. A TENS unit is an over-the-counter, FDA approved device that sends low-level electrical impulses through the skin to reduce the amount of discomfort experience...

What is the current status of trial NCT05472740?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2022-12-13. Estimated completion is 2023-12-26.

What conditions does trial NCT05472740 study?

This clinical trial studies the following conditions: Pain, Postoperative, Endometrial Diseases.

What interventions are being tested in trial NCT05472740?

The interventions under investigation include: TENS 7000 (DEVICE).

Who is sponsoring clinical trial NCT05472740?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05472740 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05472740's enrollment target sits among peer trials

149 26th of 113 higher than 88 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05472740, the US trial registry maintained by the National Library of Medicine. NCT05472740 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.